Companies in #Retinal diseases
Found 1 company operating in this sector.
EyePoint Pharmaceuticals is a clinical-stage biopharmaceutical company developing sustained-release therapeutics for serious eye disorders, including age-related macular degeneration (AMD) and diabetic macular edema. Its lead program, DURAVYU, is an intravitreal implant delivering a tyrosine kinase inhibitor for sustained VEGF suppression.